Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.87697 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.5806 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.73972 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.96749 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.80744 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.51474 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.58321 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.24105 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.2554 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.45964 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.92091 | 82 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.48284 | 78 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.56027 | 79 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.65 | 80 |